DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.6821
-0.0143 (-2.05%)
Jun 17, 2025, 11:59 AM - Market open
DarioHealth Revenue
DarioHealth had revenue of $6.75M in the quarter ending March 31, 2025, with 17.26% growth. This brings the company's revenue in the last twelve months to $28.03M, up 47.20% year-over-year. In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth.
Revenue (ttm)
$28.03M
Revenue Growth
+47.20%
P/S Ratio
1.30
Revenue / Employee
$138,782
Employees
202
Market Cap
30.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
DRIO News
- 4 weeks ago - DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - DarioHealth Reports First Quarter 2025 Financial and Operating Results - PRNewsWire
- 5 weeks ago - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations - PRNewsWire
- 5 weeks ago - DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 - PRNewsWire
- 6 weeks ago - DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives - PRNewsWire
- 2 months ago - DarioHealth Announces CFO Transition - PRNewsWire
- 2 months ago - DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers - PRNewsWire
- 2 months ago - Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion - PRNewsWire